Phreesia vs Waystar: Which One in 2026?

A partner will not accept “both vendors do revenue cycle.” They will ask which leak you are funding this year: the visit that still opens with a blank packet, or the claim that still comes back unpaid.

TL;DR: Phreesia is the visit-adjacent platform for medical practices — scheduling, registration, check-in, communication, and collecting while the patient is still in motion. Waystar is the claim-adjacent platform — eligibility at payer scale, prior authorization, claims, denials, remittances, and patient financial care after the encounter is coded. They overlap on eligibility, estimates, and patient-pay. They are not substitutes. Neither publishes a list price. Ask for a written quote that names modules, locations, interfaces, and who does the cutover work. If you need a chase loop for incomplete packets or overdue follow-ups beside either stack, start at US Tech Automations pricing.

How we evaluated

This page is for medical practices that already run an electronic chart and still lose money in the handoffs around it. We mapped one visit-to-cash path — schedule, pre-visit forms, eligibility, authorization, check-in and copay, encounter, claim, denial or pay, leftover patient balance, next chronic-care touch — and scored each product on whether its public platform pages own that step.

We opened vendor product pages for capabilities only. We did not print a subscription, per-visit, per-claim, or implementation fee, because neither vendor publishes those figures in a store a buyer can audit. Where a cell cannot be sourced, it reads “not published.” Quote drivers belong in the statement of work: locations, modules, interfaces, merchant processing, clearinghouse volume, training roles, and whether the front desk or the billing queue stays live on cutover day.

Public numbers come from regulators and trade bodies, not vendor case studies. US Tech Automations scores the pair on the path a medical practice actually runs, then points to the steps that still sit outside both products: incomplete intake recovery, form collection before the visit, and overdue chronic-care follow-up. Phreesia describes AI-enabled visit workflows and a voice agent. Waystar describes Altitude AI across financial clearance, claims, and denials. Your partner does not need a model bake-off. They need to know which queue shrinks.

Integration is assumed until the vendor names your chart and practice-management system in writing. according to ONC, 91% of office-based physicians had adopted a certified EHR as of 2024. Filing into the chart is table stakes. Replacing the record is the wrong frame.

Who Phreesia is actually for

Phreesia is for the medical practice whose pain is visible in the lobby and on the phone. The company’s public platform is built around the visit: scheduling, registration, payments, and communication on one system, with mobile self-check-in, in-office hardware for patients who will not finish on a phone, and a voice agent that handles inbound calls and outbound work such as appointments, payments, refills, recall, and collections.

If your front desk still re-keys insurance, hunts missing consents, and asks for a copay after the patient is already in the room, you are in this lane. The product story is upstream: catch inactive coverage, expired authorizations, and incomplete registration before the encounter, then ask for the balance while the patient is still present. Public pages cover merchant processing, card on file, text-to-pay, and reporting that splits pre-visit, time-of-service, and post-visit collections.

It is also for groups that want one vendor for the patient-facing surface rather than a pad, a separate texting tool, and a separate payment link. Public pages describe bidirectional interfaces with many practice-management and chart systems, a dedicated implementation team, and a live front desk during cutover. Ask for the exact interface list and day-one payment collection in the statement of work. Do not accept a slide that says “we integrate” without the feed names.

Phreesia is a weaker fit when the partner’s complaint is first-pass yield, denial workqueues, remittance posting, or payer-specific claim edits. Eligibility and registration quality can reduce junk that later becomes a denial. That is not the same as owning the claim file. If your billers live in rejection reports, keep reading.

The platform page lists HITRUST CSF, SOC 2, PCI DSS, and PCI-validated point-to-point encryption. Copy those names into your questionnaire and ask for current letters under NDA. That is diligence, not a reason to skip the workflow test.

Who Waystar is actually for

Waystar is for the medical practice whose pain is visible in the claim, the authorization queue, and the deposit. The public platform is a revenue-cycle suite: financial clearance, patient financial care, clinical integrity and revenue capture, claim and payer payment management, denial recovery, and analytics, with automation described as Altitude AI across that suite.

If your billers still work payer portals one by one, if prior authorization is a voicemail sport, or if denials recycle because nobody sees the edit until the remittance posts, you are in this lane. Financial clearance on the public site is eligibility verification, patient estimation, coverage detection, charity screening, an authorizations suite, registration quality checks, propensity-to-pay scoring, and price transparency. Claim management is edits, attachments, status, and commercial and government claims in one place. Denial recovery is avoid, track, and appeal. Patient financial care is estimates, self-service pay, and statements after the visit, including video EOBs.

It is also for groups that already have a chart and a front desk and still cannot see cash. Ask for the reports you will use in month one: first-pass yield, denial reason, days to pay, and patient-pay by location. It is a weaker fit when the complaint is the morning lobby, the after-hours phone tree, or patients who will not complete a form until someone hands them a tablet. The platform pages we opened do not publish a self-check-in pad, waiting-room hardware, or a pre-visit intake form builder as a core product. Eligibility and estimates can run before the visit. That is not owning check-in.

Enrollment and payer connectivity are the quiet work. Ask who enrolls each payer, how remittance posting is dual-run, and what happens to open denials and unposted remits on the cutover weekend. If those answers are verbal, they are not answers.

Intake versus claims, side by side

The honest comparison is not “which revenue-cycle brand is nicer.” It is which steps each product actually owns.

Capability cells reflect public product pages from Phreesia and Waystar. A cell we could not source reads “not published.” Neither vendor publishes a list price.

Both products verify coverage, estimate what the patient will owe, and collect patient-pay. That overlap is why medical practices put them on the same shortlist, and why a sloppy bake-off produces two demos that both “do eligibility.” Force the demo onto a dirty packet and a denied claim, not onto a happy-path copay. Phreesia’s eligibility story is visit-scoped: check before the patient walks in, then collect. Waystar’s is clearance-scoped: verify, estimate, detect other coverage, screen for charity, and feed the claim.

Do not let either vendor widen into the other’s job without a module list. A check-in payment does not post a professional claim. A clean-claim edit does not hand a tablet to a patient who will not finish a phone form. If a salesperson says the other job is “on the roadmap,” treat it as not published until it is on the order form.

For practices that still chase paper packets by hand, the intake recovery sequence is separate from both vendors. Automate Patient Intake Recovery Before Visits 2026 is the chase loop: find the incomplete record, message the patient, and stop the visit from opening dirty. US Tech Automations can run that chase beside Phreesia or beside a manual front desk so the reminder is not a sticky note.

If the first failure is that the form never goes out, use 5 Steps to Automate Patient Intake Forms Before Visits in 2026. That sequence is how you test Phreesia. It is not how you test Waystar.

What the public numbers say about the leak

Vendor case-study percentages do not belong on this page. The operational pressure does, and it is public.

Medicare FFS improper payments were 6.55% in FY 2025. according to CMS, the FY 2025 Medicare Fee-for-Service estimated improper payment rate is 6.55 percent, representing $28.83 billion in improper payments, with a reporting period of July 1, 2023 through June 30, 2024. according to CMS, the Part B provider improper payment rate in that same CERT release is 8.44 percent, or $9.62 billion — the line that sits closest to a medical practice’s professional claims.

Source: Centers for Medicare & Medicaid Services, Comprehensive Error Rate Testing (CERT), FY 2025. Documentation requests in the same program are due within 45 calendar days.

Those figures are not a score for either product. They are why dirty registration and missing documentation still show up as cash problems after the visit looks done. Pick the tool that sits on the miss you can show in last month’s reports.

Prior authorization is the other public drag. 95% of physicians report prior-authorization care delays. according to AMA, 95% of physicians in the 2025 prior authorization physician survey report that the process delays access to necessary care. according to AMA, more than 1 in 4 physicians (26%) report that prior authorization has led to a serious adverse event for a patient in their care. 26% of physicians report a PA-related serious adverse event.

Source: American Medical Association, 2025 prior authorization physician survey (fielded December 2025; 40% primary care / 60% specialists).

If authorization is the queue that wakes your office manager, the authorizations suite is the on-point module. An intake flag for an expired authorization is a tripwire, not a replacement for working the payer workflow. If the chart still cannot complete electronic PA — and the AMA table says most cannot — do not assume the record will absorb the job.

Eligibility data still has to come from somewhere. according to DataSpring, the organization powered by CAQH maintains more than 4.8 million provider-sourced records and connects eligibility information for more than 75% of U.S. covered lives. That is industry plumbing, not a reason to pick either product, but it is why “we check eligibility” is an incomplete demo question. Ask how often they re-check, what they do with other-party liability, and whether a failed check blocks check-in or merely paints a warning the front desk can click past.

The chart is already electronic. The remaining work is the packet, the authorization, the claim, and the follow-up.

Pros and cons

Phreesia

Pros: owns the patient-facing visit; publishes mobile, voice, and in-office hardware as one platform; puts eligibility and collections in the same check-in; gives front-office reporting a partner can read without a claims warehouse; describes a live front desk during implementation.

Cons: does not publish a claims, denial, remittance, or prior-authorization suite on the platform pages we opened; public list price is not published; hardware and merchant processing add scope a claims-only buyer does not need; overlapping eligibility with a claims vendor can double-check the same patient if you do not assign a system of record.

Waystar

Pros: owns the claim-to-cash path medical practices already staff in the back office; publishes financial clearance, authorizations, claims, denials, remits, missing-charge capture, and patient financial care as one suite; lets commercial and government claims run in one place; analytics sit on the revenue cycle rather than on the lobby.

Cons: does not publish visit hardware, self-check-in, or a pre-visit intake form builder as a core product; public list price is not published; payer enrollment and dual-run of posting are easy to under-scope; overlapping patient-pay with an intake vendor can send a patient two bills if statements are not coordinated.

What switching actually costs

You will not find a public sticker. Ask for a quote, then make the quote ugly on purpose so the hidden work cannot hide.

Neither Phreesia nor Waystar publishes these commercial figures. Treat every blank as a question, not as zero.

Data is the first real cost. An intake cutover moves patient identity, insurance, consents, card-on-file, and in-flight packets. A claims cutover moves payer enrollments, claim edits, open denials, unposted remits, and authorization records. If either vendor says “we start clean on Monday,” ask who works Tuesday’s rejections for encounters that happened last Wednesday.

Retraining is the second cost. Front-desk staff changing check-in muscle memory will slow the lobby even if the vendor handles the build. Billers changing claim-status tools will slow cash even if first-pass yield later rises. Put named super-users on the calendar. If you cannot name them, you are not ready to sign.

The month it takes is a dual-run, not a weekend. Plan for a stretch where the old path still works while the new path is proven on a subset of locations or payers. Ask each vendor for a written go-live calendar and whether check-in or claim submission stays live on cutover day. If they will not write the dual-run length, you should not write the check.

Neither product closes every loop. Incomplete packets still need a chase. Overdue chronic-care visits still need a flag. Why Are Chronic-Care Follow-Ups Slipping Through in 2026? is that flag: the patient who never became a denial because they never became a visit. US Tech Automations can watch the overdue list and open a task before the quarter closes. Extraction of card images and packet fields can sit in data extraction if staff still re-type what the patient already photographed. Orchestration across those steps is the agentic workflows layer, not a third row in the vendor table.

The verdict

Pick Phreesia if the leak you can prove is the visit: incomplete packets, unverified coverage at the desk, uncollected copays, a phone tree that eats schedulers, or no-shows you could have refilled. Pick Waystar if the leak you can prove is the claim: authorizations, first-pass failures, denial workqueues, remittance posting, missing charges, or patient balances that only appear on a statement weeks later.

If your reports show both leaks, do not pretend one license will close both. These products can coexist if you assign a system of record for eligibility and for patient-pay so the patient is not billed twice. Fund the worse leak first. Write the second product as a later phase with its own quote.

Who should pick the other one: a billing-heavy group with a calm lobby should not buy pads to avoid a claims decision. A front-desk-heavy group with clean first-pass yield should not buy a denial suite to avoid an intake decision. Send the partner back to last month’s denial-reason report and last month’s incomplete-registration list. The longer list is the product.

When you want the chase, the form chase, or the follow-up flag written as a workflow beside whichever vendor you sign, review the options on US Tech Automations and go to pricing. That is the next concrete step, not a demo theater.

FAQs

Is Phreesia a replacement for Waystar on claims?

No. Phreesia’s public platform is visit work — intake, check-in, communication, and collecting while the patient is present — not a published claims, denial, or remittance suite. Waystar’s public platform is the claim-to-cash suite. Eligibility overlap does not make them the same product.

Can a medical practice run both without double-billing patients?

Yes, if you assign one system of record for eligibility and one for patient statements and you test a full encounter through both before go-live. If you skip that assignment, patients get two asks and staff click two tools. Put the system-of-record rule in the statements of work, not in a hallway agreement.

Which one should a small independent practice fund first?

Fund the leak you can print. If yesterday’s schedule still arrived with blank packets and uncollected copays, start with Phreesia. If yesterday’s deposit still moved on denials and unposted remits, start with Waystar. Size of the practice is a quote driver, not a product picker.

How should we compare quotes when neither vendor prints a price?

Ask each vendor for the same skeleton: named modules, location count, volume band, interface list, implementation hours by role, merchant or clearinghouse fees, dual-run length, and decommission date for the tool you are turning off. Compare those lines. A lower number that omits payer enrollment or hardware is not lower.

What happens to open denials if we switch the claims platform?

They do not vanish. Require a written plan for in-flight claims, denial workqueues, and unposted remittances, including who works rejections for encounters that occurred before cutover. If the plan is “we start fresh,” cash from last week’s visits is unowned.

Key Takeaways

• Phreesia owns the visit. Waystar owns the claim. Eligibility and patient-pay are the overlap, not proof they are interchangeable.

• Neither vendor publishes a list price. A figure you cannot source does not belong in the partner memo.

• Part B improper payments were 8.44% in FY 2025. That is the CERT line closest to professional claims, and it is why documentation and coverage still matter after check-in.

• Prior authorization remains a practice-level burden in the AMA survey. If that is your queue, an authorizations suite beats an intake tripwire.

• Write the dual-run, the interface list, and the system of record for eligibility and statements into the quote. Verbal go-lives are not go-lives.

• Incomplete packets and overdue chronic-care follow-ups still need their own loops. Put a chase beside whichever vendor you pick — that is a US Tech Automations workflow step, not a reason to delay the vendor decision.

• Next step: take the worse leak and the quote skeleton to pricing.